My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nuvation Bio Inc. Class A Common Stock
(NY:
NUVB
)
3.560
-0.140 (-3.78%)
Streaming Delayed Price
Updated: 12:34 PM EDT, Oct 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Nuvation Bio Inc. Class A Common Stock
< Previous
1
2
3
Next >
Why Nuvation Bio Stock Is Skyrocketing Today
September 30, 2025
The bulls are lining up on Wall Street for this up-and-coming biotech stock.
Via
The Motley Fool
United Natural Foods Posts Upbeat Results, Joins AnaptysBio, Semtech, UiPath And Other Big Stocks Moving Higher On Tuesday
September 30, 2025
Via
Benzinga
4 Analysts Assess Nuvation Bio: What You Need To Know
September 30, 2025
Via
Benzinga
Analyst Expectations For Nuvation Bio's Future
September 08, 2025
Via
Benzinga
Guidewire Software, Samsara, Zumiez And Other Big Stocks Moving Higher On Friday
September 05, 2025
Via
Benzinga
Earnings Scheduled For August 7, 2025
August 07, 2025
Via
Benzinga
Earnings Scheduled For May 7, 2025
May 07, 2025
Via
Benzinga
Top 2 Health Care Stocks That May Plunge This Month
September 05, 2025
Via
Benzinga
NUVB Sales Jump 1,043% on Drug Launch
August 07, 2025
Via
The Motley Fool
Topics
Intellectual Property
Nuvation Bio Inc (NYSE:NUVB) Reports Mixed Q2 2025 Results with Strong Revenue Beat but Cautious Market Reaction
August 07, 2025
Nuvation Bio (NUVB) reported Q2 2025 results with a massive revenue beat ($4.83M vs. $364K est.) driven by IBTROZI launch, but EPS met expectations (-$0.17). Cash at $607.7M, pipeline progressing.
Via
Chartmill
Nuvation Bio's Ibtrozi For ROS1-Positive Lung Cancer Wins FDA Approval
June 11, 2025
FDA approves Ibtrozi for ROS1+ non-small cell lung cancer based on data from over 300 patients in two pivotal trials showing high response rates.
Via
Benzinga
Apple To $280? Here Are 10 Top Analyst Forecasts For Thursday
January 23, 2025
Via
Benzinga
UniFirst, Getty Images, Shutterstock And Other Big Stocks Moving Higher On Tuesday
January 07, 2025
Via
Benzinga
Top 4 Health Care Stocks That May Plunge This Quarter
November 11, 2024
Via
Benzinga
Fastenal Posts Upbeat Earnings, Joins Wells Fargo, JPMorgan And Other Big Stocks Moving Higher On Friday
October 11, 2024
Via
Benzinga
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
September 10, 2024
Via
Benzinga
Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data
August 05, 2024
Nuvation Bio halts its NUV-868 BET inhibitor program after Phase 1 study analysis. The decision impacts solid tumor treatments in ovarian, pancreatic, and mCRPC cancers, focusing instead on late-stage...
Via
Benzinga
NeuroBo Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
June 26, 2024
Via
Benzinga
NUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024
May 14, 2024
NUVB stock results show that Nuvation Bio beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday
April 19, 2024
Via
Benzinga
ProfoundBio Discovers The Joys Of Having A Wealthy Owner
April 08, 2024
Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a...
Via
Benzinga
Intel, XPeng And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
April 03, 2024
U.S. stock futures were lower this morning, with the Nasdaq futures falling by around 0.2% on Wednesday.
Via
Benzinga
Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal
March 30, 2024
South Korea’s AriBio out-licensed China rights for AR1001, an Alzheimer’s disease candidate, in an agreement worth up to $770 million. The company acquiring the asset asked to remain anonymous because...
Via
Talk Markets
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 27, 2024
Via
Benzinga
Cintas Reports Upbeat Earnings, Joins PaySign, Noah Holdings And Other Big Stocks Moving Higher On Wednesday
March 27, 2024
U.S. stocks were higher, with the Dow Jones index gaining around 300 points on Wednesday.
Via
Benzinga
Topics
Stocks
Why LuxUrban Hotels Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 27, 2024
Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
March 27, 2024
Via
Benzinga
Netflix To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
March 27, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket
March 27, 2024
Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 27, 2024
It's time to dive into the biggest pre-market stock movers for Wednesday morning as we check out all of the hottest news!
Via
InvestorPlace
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.